Revelation Biosciences, Inc.
REVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12,708 | $5,174 | $3,705 | $6,499 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $124 | $186 | $223 | $67 |
| Total Curr. Assets | $12,832 | $5,360 | $3,928 | $6,566 |
| Property Plant & Equip (Net) | $24 | $35 | $42 | $56 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $24 | $35 | $42 | $56 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12,856 | $5,395 | $3,970 | $6,622 |
| Liabilities | – | – | – | – |
| Payables | $1,035 | $829 | $625 | $784 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $820 | $740 | $464 | $1,130 |
| Total Curr. Liab. | $1,855 | $1,569 | $1,090 | $1,914 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,855 | $1,569 | $1,090 | $1,914 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $2 | $1 | $1 |
| Retained Earnings | -$46,908 | -$45,001 | -$42,557 | -$40,506 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $57,907 | $48,825 | $45,437 | $45,213 |
| Total Equity | $11,002 | $3,826 | $2,881 | $4,708 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12,856 | $5,395 | $3,970 | $6,622 |
| Net Debt | -$12,708 | -$5,174 | -$3,705 | -$6,499 |